- Home
- CHEK vs NUWE Comparison
CHEK vs NUWE Comparison
Compare CHEK & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- NUWE
- Stock Information
- Founded
- CHEK 2004
- NUWE 1999
- Country
- CHEK Israel
- NUWE United States
- Employees
- CHEK N/A
- NUWE N/A
- Industry
- CHEK Medical Electronics
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CHEK Health Care
- NUWE Health Care
- Exchange
- CHEK Nasdaq
- NUWE Nasdaq
- Market Cap
- CHEK 3.9M
- NUWE 3.9M
- IPO Year
- CHEK 2015
- NUWE N/A
- Fundamental
- Price
- CHEK $1.94
- NUWE $3.44
- Analyst Decision
- CHEK
- NUWE
- Analyst Count
- CHEK 0
- NUWE 0
- Target Price
- CHEK N/A
- NUWE N/A
- AVG Volume (30 Days)
- CHEK 474.1K
- NUWE 287.9K
- Earning Date
- CHEK 11-14-2025
- NUWE 11-10-2025
- Dividend Yield
- CHEK N/A
- NUWE N/A
- EPS Growth
- CHEK N/A
- NUWE N/A
- EPS
- CHEK N/A
- NUWE N/A
- Revenue
- CHEK N/A
- NUWE $8,318,000.00
- Revenue This Year
- CHEK N/A
- NUWE $6.53
- Revenue Next Year
- CHEK N/A
- NUWE $51.63
- P/E Ratio
- CHEK N/A
- NUWE N/A
- Revenue Growth
- CHEK N/A
- NUWE N/A
- 52 Week Low
- CHEK $0.56
- NUWE $3.09
- 52 Week High
- CHEK $3.13
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- CHEK 52.35
- NUWE 38.01
- Support Level
- CHEK $1.84
- NUWE $3.28
- Resistance Level
- CHEK $2.13
- NUWE $3.50
- Average True Range (ATR)
- CHEK 0.19
- NUWE 0.22
- MACD
- CHEK -0.09
- NUWE 0.07
- Stochastic Oscillator
- CHEK 16.67
- NUWE 45.56
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.